Metralindole
From Wikipedia, the free encyclopedia
![]() |
|
Systematic (IUPAC) name | |
---|---|
2,4,5,6-tetrahydro-9-methoxy-4-methyl-1H-3,4,6a-triazafluoranthene
|
|
Clinical data | |
Routes of administration |
Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 53734-79-5 |
ATC code | none |
PubChem | CID 68713 |
ChemSpider | 61964 |
UNII | 2QW3FL6OPA ![]() |
Chemical data | |
Formula | C15H17N3O |
Molar mass | 255.32 g/mol |
3D model (Jmol) | Interactive image |
|
Metralindole (Inkazan) is a reversible inhibitor of monoamine oxidase A (RIMA) which was investigated in Russia as a potential antidepressant.[1] It is structurally and pharmacologically related to pirlindole.
See also[edit]
References[edit]
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |